Short version: amyloid matters, but it is not the whole disease. The National Institute on Aging says Alzheimer’s involves beta-amyloid plaques, tau, inflammation, and other biology, which is why decades of anti-amyloid drugs produced many failures or only modest benefit. Timing also matters. Once brain damage is advanced, removing plaque does not restore lost neurons.
The newer anti-amyloid drugs, like lecanemab and donanemab, are approved for early Alzheimer’s and can slow decline somewhat, but they do not reverse the disease. That is why the field is moving toward earlier treatment and a broader target list instead of betting everything on one protein.
Sources
This is general information, not professional medical advice. For decisions about your situation, talk to a qualified professional.
More in Health
Are dates and date syrups actually better for blood sugar than refined cane sugar?
Dates may be gentler than table sugar, but they are still sugar and still count.
🩺 Health 15 weeks ago 2 min readAre humans more bacteria than human cells?
The old '10:1 bacteria-to-human-cells' claim is overstated — the real ratio is closer to 1:1 — but bacteria still account for roughly as much mass in your body as your brain, and they run a surprising amount of your chemistry.
🩺 Health 5 weeks ago 4 min readAre natural sweeteners like allulose and monk fruit truly safer than aspartame or stevia?
“Natural” does not automatically mean safer; approved sweeteners are usually fine in normal amounts.
🩺 Health 15 weeks ago 2 min read